These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21878972)

  • 21. Conflict-of-interest debate stirs mixed reaction at NIH.
    Macilwain C
    Nature; 1994 Feb; 367(6462):401. PubMed ID: 8107786
    [No Abstract]   [Full Text] [Related]  

  • 22. Menelas Pangalos. Interview by Asher Mullard.
    Mullard A
    Nat Rev Drug Discov; 2013 Jun; 12(6):418. PubMed ID: 23722338
    [No Abstract]   [Full Text] [Related]  

  • 23. Richard Bergström. Interview by Asher Mullard.
    Bergström R
    Nat Rev Drug Discov; 2011 Jun; 10(6):408. PubMed ID: 21629284
    [No Abstract]   [Full Text] [Related]  

  • 24. Animal research: a call for legislative reform requiring ethical merit review.
    Brody M
    HELR Harvard Environ Law Rev; 1989; 13(2):423-84. PubMed ID: 11659214
    [No Abstract]   [Full Text] [Related]  

  • 25. Squabbling all the way to the genebank.
    Kleiner K
    New Sci; 1994 Nov; 144(1953):14-5. PubMed ID: 11656411
    [No Abstract]   [Full Text] [Related]  

  • 26. Invited lectures related to patient-centered outcomes research.
    Hache M; Kazim R
    J Neurosurg Anesthesiol; 2012 Oct; 24(4):389-90. PubMed ID: 23085785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical research: outlook from industry.
    Echols R
    Clin Perform Qual Health Care; 1996; 4(2):113-4. PubMed ID: 10156942
    [No Abstract]   [Full Text] [Related]  

  • 28. Ethics. Senate probe of research psychiatrists.
    Kaiser J
    Science; 2009 Jul; 325(5936):30. PubMed ID: 19574367
    [No Abstract]   [Full Text] [Related]  

  • 29. A brave new medicine. A conversation with William Haseltine.. Interview by Joe Flower.
    Hasetine W
    Health Forum J; 1999; 42(4):28-30, 61-5. PubMed ID: 10539016
    [No Abstract]   [Full Text] [Related]  

  • 30. "NIH-money-for-drug-patent-life" proposal rejected.
    Fox JL
    Nat Biotechnol; 1997 Dec; 15(13):1338. PubMed ID: 9415880
    [No Abstract]   [Full Text] [Related]  

  • 31. Macro trends in pharmaceutical innovation.
    Cohen FJ
    Nat Rev Drug Discov; 2005 Jan; 4(1):78-84. PubMed ID: 15688075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The National Cancer Institute's Drug Development Program.
    Schepartz SA
    Prog Clin Biol Res; 1985; 197():73-82. PubMed ID: 4070301
    [No Abstract]   [Full Text] [Related]  

  • 33. NIH drops reasonable pricing clause.
    Gavaghan H
    Nature; 1995 Apr; 374(6524):669. PubMed ID: 7715715
    [No Abstract]   [Full Text] [Related]  

  • 34. Opening up the Ivory Tower.
    Wilan KH
    Cell; 2007 Jun; 129(5):847-50. PubMed ID: 17540161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An audience with Guido Rasi. Interview by Asher Mullard.
    Rasi G
    Nat Rev Drug Discov; 2012 Mar; 11(3):182. PubMed ID: 22378260
    [No Abstract]   [Full Text] [Related]  

  • 36. Marc Kirschner. Interview by Asher Mullard.
    Kirschner M
    Nat Rev Drug Discov; 2011 Dec; 10(12):894. PubMed ID: 22129982
    [No Abstract]   [Full Text] [Related]  

  • 37. Orphan products development and some methods for maximizing the usefulness of research on rare diseases.
    Finkel MJ
    Prog Clin Biol Res; 1985; 197():11-8. PubMed ID: 4070285
    [No Abstract]   [Full Text] [Related]  

  • 38. US health bill promises changes for biomedical researchers.
    Wadman M
    Nature; 2010 Mar; 464(7288):479. PubMed ID: 20336105
    [No Abstract]   [Full Text] [Related]  

  • 39. Advisors may urge NIH to seek out industry support for clinical trials.
    Appel A
    Nature; 1995 Nov; 378(6553):116. PubMed ID: 7477301
    [No Abstract]   [Full Text] [Related]  

  • 40. Trevor Mundel. Interview by Asher Mullard.
    Nat Rev Drug Discov; 2012 Mar; 11(4):264-5. PubMed ID: 22460116
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.